IL-8 levels in PRP and PPP of patients with MMM or healthy subjects
. | IL-8, pg/mL . | . | |
|---|---|---|---|
| Sample . | PRP* . | PPP . | |
| H1 | 46 | < 8 | |
| H2 | < 8 | < 8 | |
| H3 | < 8 | < 8 | |
| MMM1 | 252 | 72 | |
| MMM2 | 249 | 54 | |
| MMM4 | 324 | 77 | |
| MMM11 | 64 | < 8 | |
| MMM12 | 96 | < 8 | |
. | IL-8, pg/mL . | . | |
|---|---|---|---|
| Sample . | PRP* . | PPP . | |
| H1 | 46 | < 8 | |
| H2 | < 8 | < 8 | |
| H3 | < 8 | < 8 | |
| MMM1 | 252 | 72 | |
| MMM2 | 249 | 54 | |
| MMM4 | 324 | 77 | |
| MMM11 | 64 | < 8 | |
| MMM12 | 96 | < 8 | |
H indicates healthy donor; MMM, patients with MMM.
IL-8 concentrations were assessed by means of an IL-8 ELISA kit. The threshold sensitivity for the IL-8 ELISA was ≥ 8 pg/mL.
Indicates significant difference between PRP and PPP values for H and MMM subjects; P < .05.